A new antibody treatment that could decrease hospital time for people infected with COVID-19 will be distributed to hospitals and skilled nursing facilities in San Bernardino County.
The U.S. government paid for the distribution of 484 units of Bamlanivimab to the San Bernardino County Department of Public Health, according to a statement on the county’s website.
The antibody, from Eli Lilly, is similar to the Regeneron treatment given to President Donald Trump during his hospitalization in October, although it was for more critically ill patients.
“This medication will allow our county to treat a significant share of our high-risk patients who do not require hospitalization,” said Dr. Erin Gustafson, the county’s acting public health officer, in the statement. “We are hopeful that this therapy will help residents who can take it to recover quickly from this virus.”
Tests have shown that Bamlanivimab can reduce a patient’s hospital time if it’s administered early in the infection, according to the statement.